Imaging Biomarkers for TMS Treatment of Depression
This study is researching all of the following topics:Depression
Location of study visits:
Ann Arbor, MI
This study is looking for:
Both men and women
Volunteers with specific conditions
This research studies people with depression who are experiencing symptoms after trying antidepressant medications.
Using a relatively new FDA-approved treatment called repetitive transcranial magnetic stimulation (rTMS) and brain imaging we will see how rTMS works to reduce symptoms of depression.
What is involved?There are three parts to this study:
1) A psychiatric assessment to learn more about your background and your symptom history to confirm that you are eligible to take part.
2) Two functional magnetic resonance imaging (fMRI) scans to measure changes in your brain activity before and after rTMS treatment.
3) Up to 45 rTMS sessions.
Eligible subjects will need to be on a current and stable dose of antidepressant medications for at least 4 weeks prior to enrolling.IRB number: HUM00053677 Study posted on: 08/27/2013 Posting will be taken down on: 10/31/2015
Study TeamPrincipal Investigator: Taylor, Stephan FDepartment: Psychiatry